Lagis Enterprise Co., Ltd. (TPEX:6730)
Taiwan · Delayed Price · Currency is TWD 33.40
+0.60 (1.83%)
Jul 30, 2026, 1:30 PM CST
Lagis Enterprise Market Cap
Lagis Enterprise has a market cap or net worth of 1.19 billion as of July 29, 2026. Its market cap has decreased by -17.25% in one year.
Market Cap
1.19B
Enterprise Value
1.36B
Revenue
486.50M
Ranking
n/a
PE Ratio
16.38
Stock Price
33.40
ChartMarket Cap Chart
Since November 8, 2019, Lagis Enterprise's market cap has decreased from 2.35B to 1.19B, a decrease of -49.40%. That is a compound annual growth rate of -9.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.19B | -7.34% |
| Dec 31, 2025 | 1.28B | 4.16% |
| Dec 31, 2024 | 1.23B | 1.45% |
| Dec 29, 2023 | 1.22B | 17.47% |
| Dec 29, 2022 | 1.04B | -2.56% |
| Dec 30, 2021 | 1.06B | -4.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maxigen Biotech | 3.61B |
| ICARES Medicus | 3.36B |
| Nang Kuang Pharmaceutical | 3.21B |
| Chi Sheng Pharma & Biotech | 1.80B |
| Crystalvue Medical | 1.74B |
| BenQ Medical Technology | 1.72B |
| Ttbio | 1.28B |
| Concord Medical | 1.05B |